Suma Krishnan
President, R&D, Director, 10% Owner · Krystal Biotech, Inc.
- 2024
- Sep 4, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Suma Krishnan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Krish S. Krishnan - $34.27M in KRYS purchases and sales in the last 12 months
- Daniel Janney - $19.40M in KRYS purchases and sales in the last 12 months
- Dino A. Rossi - $13.18M in KRYS purchases and sales in the last 12 months
- Kathryn Romano - $3.60M in KRYS purchases and sales in the last 12 months
- John Charles Thomas - $541K in KRYS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Suma Krishnan?
Suma Krishnan is a corporate insider, tracked as President, R&D, Director, 10% Owner of Krystal Biotech, Inc. (KRYS). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Suma Krishnan submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Suma Krishnan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 82 open-market sales ($50.03M) across all tracked filings.
